Caspase 12: Difference between revisions
No edit summary |
Flagging sources with dois highlighted by RetractionWatch. |
||
(24 intermediate revisions by 19 users not shown) | |||
Line 1: | Line 1: | ||
{{Short description|Protein found in humans}} |
|||
{{Use dmy dates|date= |
{{Use dmy dates|date=September 2022}} |
||
{{infobox protein |
|||
{{Infobox gene}} |
|||
| Name = caspase 12 |
|||
⚫ | '''Caspase 12''' is a [[protein]] that in humans is encoded by the ''CASP12'' [[gene]]. The protein belongs to a family of [[enzyme]]s called [[caspase]]s which cleave their [[Substrate (biochemistry)|substrate]]s at [[C-terminal]] [[aspartic acid]] residues. It is closely related to [[caspase 1]] and other members of the caspase family, known as inflammatory caspases, which process and activate inflammatory [[cytokine]]s such as [[interleukin 1]] and [[interleukin 18]]. |
||
| caption = |
|||
| image = |
|||
| width = 240px |
|||
| HGNCid = 19004 |
|||
| Symbol = CASP12 |
|||
| AltSymbols = CASP12P1 |
|||
| EntrezGene = 120329 |
|||
| OMIM = 608633 |
|||
| RefSeq = NR_000035 |
|||
| UniProt = Q6UXS9 |
|||
| PDB = |
|||
| ECnumber = |
|||
| Chromosome = 11 |
|||
| Arm = q |
|||
| Band = 22.3 |
|||
| LocusSupplementaryData = |
|||
}} |
|||
⚫ | '''Caspase 12''' is a [[protein]] that belongs to a family of [[enzyme]]s called [[caspase]]s which cleave their [[Substrate (biochemistry)|substrate]]s at [[C-terminal]] [[aspartic acid]] residues. It is closely related to [[caspase 1]] and other members of the caspase family, known as inflammatory caspases, which process and activate inflammatory [[cytokine]]s such as [[interleukin 1]] and [[interleukin 18]]. |
||
== Gene == |
== Gene == |
||
It is found on [[chromosome |
It is found on [[chromosome 11]] in humans in a [[Locus (genetics)|locus]] with other inflammatory caspases.<ref>{{cite journal |vauthors=Fischer H, Koenig U, Eckhart L, Tschachler E |title=Human caspase 12 has acquired deleterious mutations |journal=Biochem. Biophys. Res. Commun. |volume=293 |issue=2 |pages=722–6 |year=2002 |pmid=12054529 |doi=10.1016/S0006-291X(02)00289-9}}</ref> |
||
''CASP12'' [[orthologs]]<ref name="OrthoMaM">{{cite web |
''CASP12'' [[orthologs]]<ref name="OrthoMaM">{{cite web|title=OrthoMaM phylogenetic marker: CASP12 coding sequence |url=http://www.orthomam.univ-montp2.fr/orthomam/data/cds/detailMarkers/ENSG00000204403_CASP12.xml }}{{dead link|date=November 2016 |bot=InternetArchiveBot |fix-attempted=yes }}</ref> have been identified in numerous [[mammal]]s for which complete genome data are available. |
||
== Clinical significance == |
== Clinical significance == |
||
The CASP12 [[gene]] is subject to [[Polymorphism (biology)|polymorphism]], which can generate a full |
The CASP12 [[gene]] is subject to [[Polymorphism (biology)|polymorphism]], which can generate a full-length caspase protein (Csp12L) or an inactive truncated form (Csp12S). The functional form appears to be confined to people of [[Ethnic groups of Africa|African]] descent and is linked with susceptibility to [[sepsis]]; people carrying the functional gene have decreased responses to bacterial molecules such as [[lipopolysaccharide]] (LPS).<ref>{{cite journal |vauthors=Saleh M, Vaillancourt JP, Graham RK, Huyck M, Srinivasula SM, Alnemri ES, Steinberg MH, Nolan V, Baldwin CT, Hotchkiss RS, Buchman TG, Zehnbauer BA, Hayden MR, Farrer LA, Roy S, Nicholson DW |title=Differential modulation of endotoxin responsiveness by human caspase-12 polymorphisms |journal=Nature |volume=429 |issue=6987 |pages=75–9 |year=2004 |pmid=15129283 |doi=10.1038/nature02451|bibcode=2004Natur.429...75S |doi-access=free }}</ref><ref>{{cite journal |author=Saleh, Maya Mathison |author2=John C. Wolinski |author3=Melissa K. Bensinger |author4=Steve J. Fitzgerald |author5=Patrick Droin |author6=Nathalie Ulevitch |author7=Richard J. Green |author8=Douglas R. Nicholson |author9=Donald W. |title=Enhanced bacterial clearance and sepsis resistance in caspase-12-deficient mice |journal=Nature |volume=440 |issue=7087 |pages=1064–1068 |year=2006 |doi=10.1038/nature04656 |pmid=16625199 |bibcode=2006Natur.440.1064S |s2cid=4321520 }}{{Erratum|doi=10.1038/nature04656|pmid=16625199|checked=yes}}</ref> |
||
A study in May 2009 by McGill University Health Centre has suggested that [[estrogen]] may serve to block the production of caspase-12, resulting in a stronger inflammatory reaction to bacterial pathogens. The trials were carried out on laboratory mice which had been implanted with the human caspase-12 gene.<ref name="pmid19447924">{{cite journal | |
A study in May 2009 by McGill University Health Centre has suggested that [[estrogen]] may serve to block the production of caspase-12, resulting in a stronger inflammatory reaction to bacterial pathogens. The trials were carried out on laboratory mice which had been implanted with the human caspase-12 gene.<ref name="pmid19447924">{{cite journal | vauthors = Yeretssian G, Doiron K, Shao W, Leavitt BR, Hayden MR, Nicholson DW, Saleh M | title = Gender differences in expression of the human caspase-12 long variant determines susceptibility to Listeria monocytogenes infection | journal = Proc. Natl. Acad. Sci. U.S.A. | volume = 106| issue = 22| pages = 9016–20|date=May 2009 | pmid = 19447924 | doi = 10.1073/pnas.0813362106 | pmc = 2690057 | bibcode = 2009PNAS..106.9016Y | doi-access = free }}</ref><ref name="urlNHS">{{cite web | url = http://www.nhs.uk/news/2009/05May/Pages/Manflurealormyth.aspx | title = Man flu: real or myth? | date = 2009-05-18 | work = Health | publisher = NHS UK | access-date = 23 May 2009 | archive-date = 16 February 2010 | archive-url = https://web.archive.org/web/20100216113214/http://www.nhs.uk/news/2009/05May/Pages/Manflurealormyth.aspx | url-status = dead }}</ref><ref name="urlBBC">{{cite web | url = http://news.bbc.co.uk/1/hi/health/8047321.stm | title = Women 'fight off disease better' | date = 2009-05-13 | work = Health | publisher = BBC News | accessdate = 2009-05-13}}</ref> |
||
The inactive truncated form (Csp12S) of the CASP12 [[gene]] was spread and nearly fixed in non-African populations due to [[Directional selection|positive selection]] beginning perhaps 60–100 thousand years ago. Its selective advantage is thought to be sepsis resistance in populations that experienced more infectious diseases as population sizes and densities increased.<ref>{{cite journal |
The inactive truncated form (Csp12S) of the CASP12 [[gene]] was spread and nearly fixed in non-African populations due to [[Directional selection|positive selection]] beginning perhaps 60–100 thousand years ago. Its selective advantage is thought to be sepsis resistance in populations that experienced more infectious diseases as population sizes and densities increased.<ref>{{cite journal | doi=10.1086/503116 | volume=78 | issue=4 | title=Spread of an Inactive Form of Caspase-12 in Humans Is Due to Recent Positive Selection | journal=The American Journal of Human Genetics | pages=659–670 | pmid=16532395 | pmc=1424700| year=2006 | last1=Xue | first1=Yali | last2=Daly | first2=Allan | last3=Yngvadottir | first3=Bryndis | last4=Liu | first4=Mengning | last5=Coop | first5=Graham | last6=Kim | first6=Yuseob | last7=Sabeti | first7=Pardis |author7-link=Pardis Sabeti | last8=Chen | first8=Yuan | last9=Stalker | first9=Jim | last10=Huckle | first10=Elizabeth | last11=Burton | first11=John | last12=Leonard | first12=Steven | last13=Rogers | first13=Jane | last14=Tyler-Smith | first14=Chris }}</ref><ref>{{cite journal | doi = 10.1371/journal.pbio.0040052 | volume=4 | issue=3 | title=Gene Losses during Human Origins | journal=PLOS Biology | pages=e52 | pmid=16464126 | pmc=1361800| year=2006 | last1=Wang | first1=Xiaoxia | last2=Grus | first2=Wendy E. | last3=Zhang | first3=Jianzhi | doi-access=free }}</ref> |
||
==References== |
==References== |
||
{{Reflist |
{{Reflist}} |
||
==External links== |
==External links== |
||
* The [[MEROPS]] online database for peptidases and their inhibitors: [http://merops.sanger.ac.uk/cgi-bin/merops.cgi?id=C14.013 C14.013] |
* The [[MEROPS]] online database for peptidases and their inhibitors: [http://merops.sanger.ac.uk/cgi-bin/merops.cgi?id=C14.013 C14.013] {{Webarchive|url=https://web.archive.org/web/20050906225501/http://merops.sanger.ac.uk/cgi-bin/merops.cgi?id=C14.013 |date=6 September 2005 }} |
||
{{Cysteine proteases}} |
{{Cysteine proteases}} |
||
{{Enzymes}} |
{{Enzymes}} |
||
{{Portal bar| |
{{Portal bar|Biology|border=no}} |
||
[[Category:EC 3.4.22]] |
[[Category:EC 3.4.22]] |
||
[[Category:Caspases]] |
Latest revision as of 07:46, 7 July 2024
CASP12 | |||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Identifiers | |||||||||||||||||||||||||||||||||||||||||||||||||||
Aliases | CASP12, CASP-12, CASP12P1, caspase 12 (gene/pseudogene), caspase 12, Caspase-12, Caspase_12, IPR035713 | ||||||||||||||||||||||||||||||||||||||||||||||||||
External IDs | OMIM: 608633; MGI: 1312922; GeneCards: CASP12; OMA:CASP12 - orthologs | ||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||
Wikidata | |||||||||||||||||||||||||||||||||||||||||||||||||||
|
Caspase 12 is a protein that in humans is encoded by the CASP12 gene. The protein belongs to a family of enzymes called caspases which cleave their substrates at C-terminal aspartic acid residues. It is closely related to caspase 1 and other members of the caspase family, known as inflammatory caspases, which process and activate inflammatory cytokines such as interleukin 1 and interleukin 18.
Gene
[edit]It is found on chromosome 11 in humans in a locus with other inflammatory caspases.[5] CASP12 orthologs[6] have been identified in numerous mammals for which complete genome data are available.
Clinical significance
[edit]The CASP12 gene is subject to polymorphism, which can generate a full-length caspase protein (Csp12L) or an inactive truncated form (Csp12S). The functional form appears to be confined to people of African descent and is linked with susceptibility to sepsis; people carrying the functional gene have decreased responses to bacterial molecules such as lipopolysaccharide (LPS).[7][8]
A study in May 2009 by McGill University Health Centre has suggested that estrogen may serve to block the production of caspase-12, resulting in a stronger inflammatory reaction to bacterial pathogens. The trials were carried out on laboratory mice which had been implanted with the human caspase-12 gene.[9][10][11]
The inactive truncated form (Csp12S) of the CASP12 gene was spread and nearly fixed in non-African populations due to positive selection beginning perhaps 60–100 thousand years ago. Its selective advantage is thought to be sepsis resistance in populations that experienced more infectious diseases as population sizes and densities increased.[12][13]
References
[edit]- ^ a b c GRCh38: Ensembl release 89: ENSG00000204403 – Ensembl, May 2017
- ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000025887 – Ensembl, May 2017
- ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ^ Fischer H, Koenig U, Eckhart L, Tschachler E (2002). "Human caspase 12 has acquired deleterious mutations". Biochem. Biophys. Res. Commun. 293 (2): 722–6. doi:10.1016/S0006-291X(02)00289-9. PMID 12054529.
- ^ "OrthoMaM phylogenetic marker: CASP12 coding sequence".[permanent dead link ]
- ^ Saleh M, Vaillancourt JP, Graham RK, Huyck M, Srinivasula SM, Alnemri ES, Steinberg MH, Nolan V, Baldwin CT, Hotchkiss RS, Buchman TG, Zehnbauer BA, Hayden MR, Farrer LA, Roy S, Nicholson DW (2004). "Differential modulation of endotoxin responsiveness by human caspase-12 polymorphisms". Nature. 429 (6987): 75–9. Bibcode:2004Natur.429...75S. doi:10.1038/nature02451. PMID 15129283.
- ^ Saleh, Maya Mathison; John C. Wolinski; Melissa K. Bensinger; Steve J. Fitzgerald; Patrick Droin; Nathalie Ulevitch; Richard J. Green; Douglas R. Nicholson; Donald W. (2006). "Enhanced bacterial clearance and sepsis resistance in caspase-12-deficient mice". Nature. 440 (7087): 1064–1068. Bibcode:2006Natur.440.1064S. doi:10.1038/nature04656. PMID 16625199. S2CID 4321520. (Erratum: doi:10.1038/nature04656, PMID 16625199)
- ^ Yeretssian G, Doiron K, Shao W, Leavitt BR, Hayden MR, Nicholson DW, Saleh M (May 2009). "Gender differences in expression of the human caspase-12 long variant determines susceptibility to Listeria monocytogenes infection". Proc. Natl. Acad. Sci. U.S.A. 106 (22): 9016–20. Bibcode:2009PNAS..106.9016Y. doi:10.1073/pnas.0813362106. PMC 2690057. PMID 19447924.
- ^ "Man flu: real or myth?". Health. NHS UK. 18 May 2009. Archived from the original on 16 February 2010. Retrieved 23 May 2009.
- ^ "Women 'fight off disease better'". Health. BBC News. 13 May 2009. Retrieved 13 May 2009.
- ^ Xue, Yali; Daly, Allan; Yngvadottir, Bryndis; Liu, Mengning; Coop, Graham; Kim, Yuseob; Sabeti, Pardis; Chen, Yuan; Stalker, Jim; Huckle, Elizabeth; Burton, John; Leonard, Steven; Rogers, Jane; Tyler-Smith, Chris (2006). "Spread of an Inactive Form of Caspase-12 in Humans Is Due to Recent Positive Selection". The American Journal of Human Genetics. 78 (4): 659–670. doi:10.1086/503116. PMC 1424700. PMID 16532395.
- ^ Wang, Xiaoxia; Grus, Wendy E.; Zhang, Jianzhi (2006). "Gene Losses during Human Origins". PLOS Biology. 4 (3): e52. doi:10.1371/journal.pbio.0040052. PMC 1361800. PMID 16464126.
External links
[edit]- The MEROPS online database for peptidases and their inhibitors: C14.013 Archived 6 September 2005 at the Wayback Machine